Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
Retrovirology. 2018 Dec 22;15(1):79. doi: 10.1186/s12977-018-0462-x.
Human immunodeficiency virus (HIV) infection, despite great advances in antiretroviral therapy, remains a lifelong affliction. Though current treatment regimens can effectively suppress viral load to undetectable levels and preserve healthy immune function, they cannot fully alleviate all symptoms caused by the presence of the virus, such as HIV-associated neurocognitive disorders. Exosomes are small vesicles that transport cellular proteins, RNA, and small molecules between cells as a mechanism of intercellular communication. Recent research has shown that HIV proteins and RNA can be packaged into exosomes and transported between cells, to pathogenic effect. This review summarizes the current knowledge on the diverse mechanisms involved in the sorting of viral elements into exosomes and the damage those exosomal agents can inflict. In addition, potential therapeutic options to counteract exosome-mediated HIV pathogenesis are reviewed and considered.
人类免疫缺陷病毒(HIV)感染,尽管在抗逆转录病毒治疗方面取得了巨大进展,但仍然是一种终身疾病。尽管目前的治疗方案可以有效地将病毒载量抑制到无法检测的水平,并保持健康的免疫功能,但它们并不能完全缓解病毒存在引起的所有症状,如 HIV 相关的神经认知障碍。外泌体是一种小泡,可作为细胞间通讯的机制在细胞间运输细胞蛋白、RNA 和小分子。最近的研究表明,HIV 蛋白和 RNA 可以被包装到外泌体中,并在细胞间运输,产生致病作用。本综述总结了目前关于病毒成分分类到外泌体的多种机制以及这些外泌体物质可能造成的损害的知识。此外,还综述和考虑了对抗外泌体介导的 HIV 发病机制的潜在治疗选择。